EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Analgosedation for catheter ablation in deep sedation: comparison between cryoballoon and pulsed field ablation

Moritz Nies iD, Laura Rottner iD, Ingrid Unruh, Julius Obergassel iD, Jan Rieß iD, Niklas Schenker iD, Djemail Ismaili iD, Maria Luisa Benesch Vidal iD, Dominik Christmann, Johanna Skibowski, Lea Scharlemann, Christoph Otto iD und 7 weitere

Europace · 02.06.2026 · 28 (6)

DOI: 10.1093/europace/euag126 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Europace, online erschienen am 11.06.2026. Verfasst von Moritz Nies und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, University Medical Center Hamburg-Eppendorf, Martinistraße 52, Hamburg 20246, Germany. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University Medical Centre Hamburg.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pulsed field ablation (PFA) has been established as a viable alternative to thermal ablation for pulmonary vein isolation (PVI).1–3 Although general anaesthesia was recommended in early stages, deep sedation has been shown to be safe and feasible for the pentaspline (ps) PFA system.4–6 Skeletal muscle activation, phrenic nerve stimulation, and oesophageal contraction have caused discussions about sedation protocols for PFA in deep sedation.7 Data on the dose of sedation agents during PFA procedures as compared to cryoballoon ablation (CBA) are scarce and stem from small patient cohorts.8 This sub-analysis from a prospective, all-comer registry study aimed at comparing the use of sedation and analgesia medication and safety during index PVI using CBA and psPFA. Patients undergoing index PVI in deep sedation were consecutively enrolled into TRUST, a prospective, single-centre, clinical cohort study (NCT05521451).9 Data of this study are available upon reasonable request. Ablation workflows for CBA and psPFA have been described before.10 No adjunctive ablation sets other than PVI were included for this analysis. Patients who underwent general anaesthesia (e.g. due to severe obesity with a body mass index ≥40 kg/m2, severe pulmonary comorbidity) were excluded. The ablation modality depended on system availability in the respective electrophysiology laboratories, irrespective of patient characteristics. Analgosedation was delivered by a centralized team consisting of cardiologists and specifically trained EP-nurses, operating uniformly across all electrophysiology laboratories. No standard premedication was administered before the procedure. Sedation was initiated using a bolus of 0.5 mg/kg propofol and 25 µg fentanyl and maintained via continuous propofol infusion at 6–7 mg/(kg*h). Additional boli or higher propofol rates were applied when sedation depth or analgesia were deemed insufficient (e.g. motoric reactions to PFA applications or increases in blood-pressure). Intraprocedural monitoring included continuous measurement of blood oxygen saturation, ECG, and non-invasive blood-pressure measurement at 5 min-intervals (or more frequently if needed). To account for procedure time and patient weight, propofol and fentanyl doses were indexed to both parameters (mg/(kg*min); ng/(kg*min)). All analyses were exploratory using appropriate univariate testing. Two-sided P-values

Schlagwörter

Stichwörter der Autor:innen

AnalgesiaAtrial fibrillationDeep sedationPulmonary vein isolationPulsed field ablation

Autor:innen und Institutionen

  • Department of Cardiology, University Medical Center Hamburg-Eppendorf, Martinistraße 52, Hamburg 20246, Germany.
  • German Center for Cardiovascular Research (DZHK), Partner Site North, Germany.
  • Department of Cardiology, Universitäres Herz- und Gefässzentrum Frankfurt, Frankfurt, Germany.

ORCID-Profile: Moritz Nies, Laura Rottner, Julius Obergassel, Jan Rieß, Niklas Schenker, Djemail Ismaili, Maria Luisa Benesch Vidal, Christoph Otto, Shinwan Kany, Marc D Lemoine, Bruno Reißmann, Feifan Ouyang, Paulus Kirchhof, Andreas Metzner, Andreas Rillig

Förderung

  • University Medical Centre Hamburg

Zitieren

APA

Nies, M., Rottner, L., Unruh, I., Obergassel, J., Rieß, J., Schenker, N., Ismaili, D., Benesch Vidal, M. L., Christmann, D., Skibowski, J., Scharlemann, L., Otto, C., Kany, S., Lemoine, M. D., Reißmann, B., Ouyang, F., Kirchhof, P., Metzner, A., & Rillig, A. (2026). Analgosedation for catheter ablation in deep sedation: comparison between cryoballoon and pulsed field ablation. Europace, 28(6). https://doi.org/10.1093/europace/euag126

Vancouver

Nies M, Rottner L, Unruh I, Obergassel J, Rieß J, Schenker N, et al. Analgosedation for catheter ablation in deep sedation: comparison between cryoballoon and pulsed field ablation. Europace. 2026;28(6). doi:10.1093/europace/euag126

BibTeX
@article{Nies2026,
  author = {Nies, Moritz and Rottner, Laura and Unruh, Ingrid and Obergassel, Julius and Rieß, Jan and Schenker, Niklas and Ismaili, Djemail and Benesch Vidal, Maria Luisa and Christmann, Dominik and Skibowski, Johanna and Scharlemann, Lea and Otto, Christoph and Kany, Shinwan and Lemoine, Marc D and Reißmann, Bruno and Ouyang, Feifan and Kirchhof, Paulus and Metzner, Andreas and Rillig, Andreas},
  title = {Analgosedation for catheter ablation in deep sedation: comparison between cryoballoon and pulsed field ablation},
  journal = {Europace},
  year = {2026},
  volume = {28},
  number = {6},
  doi = {10.1093/europace/euag126}
}
Kostenlos starten →